The proposal aims to reduce out-of-pocket costs for a number of anti-obesity medications by 95%.
Biden-Harris Administration Proposes Expansion to Medicare and Medicaid to Include Anti-Obesity Medications
You May Also Like
Global Launch Strategies in the Current Political Climate
February 19, 2025
FDA Approves Samsung Bioepis Biosimilars Ospomyv and Xbryk
February 19, 2025
Navigating Distrust: Pharma in the Age of Social Media
February 18, 2025
+ There are no comments
Add yours